Dataset Information

The image-scratch paradigm: a new paradigm for evaluating infants' motivated gaze control.

ABSTRACT: Human infants show spontaneous behaviours such as general movement, goal-directed behaviour, and self-motivated behaviour from a very early age. However, it is unclear how these behaviours are organised throughout development. A major hindrance to empirical investigation is that there is no common paradigm for all ages that can circumvent infants' underdeveloped verbal and motor abilities. Here, we propose a new paradigm, named the image-scratch task, using a gaze-contingent technique that is adaptable to various extents of motor ability. In this task, participants scratch off a black layer on a display to uncover pictures beneath it by using their gaze. We established quantitative criteria for spontaneous eye-movement based on adults' gaze-data and demonstrated that our task is useful for evaluating eye-movements motivated by outcome attractiveness in 8-month-olds. Finally, we discuss the potential of this paradigm for revealing the mechanisms and developmental transitions underlying infants' spontaneous and intentional behaviours.

SUBMITTER: Miyazaki M

PROVIDER: S-EPMC4074783 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

The image-scratch paradigm: a new paradigm for evaluating infants' motivated gaze control.

Miyazaki Michiko M Takahashi Hideyuki H Rolf Matthias M Okada Hiroyuki H Omori Takashi T

Scientific reports 20140630

Human infants show spontaneous behaviours such as general movement, goal-directed behaviour, and self-motivated behaviour from a very early age. However, it is unclear how these behaviours are organised throughout development. A major hindrance to empirical investigation is that there is no common paradigm for all ages that can circumvent infants' underdeveloped verbal and motor abilities. Here, we propose a new paradigm, named the image-scratch task, using a gaze-contingent technique that is ad ...[more]

PMID: 24975349

Similar Datasets

Project description:BACKGROUND:Attentional biases, namely difficulties both to disengage attention from negative information and to maintain it on positive information, play an important role in the onset and maintenance of the disorder. Recently, researchers have developed specific attentional bias modification (ABM) techniques aimed to modify these maladaptive attentional patterns. However, the application of current ABM procedures has yielded, so far, scarce results in depression due, in part, to some methodological shortcomings. The aim of our protocol is the application of a new ABM technique, based on eye-tracker technology, designed to objectively train the specific attentional components involved in depression and, eventually, to reduce depressive symptoms. METHODS:Based on sample size calculations, 32 dysphoric (BDI ?13) participants will be allocated to either an active attentional bias training group or a yoked-control group. Attentional training will be individually administered on two sessions in two consecutive days at the lab. In the training task series of pairs of faces (i.e. neutral vs. sad; neutral vs. happy; happy vs. sad) will be displayed. Participants in the training group will be asked to localize as quickly as possible the most positive face of the pair (e.g., the neutral face in neutral vs. sad trials) and maintain their gaze on it for 750 ms or 1500 ms, in two different blocks, to advance to the next trial. Participants' maintenance of gaze will be measured by an eye-tracking apparatus. Participants in the yoked-control group will be exposed to the same stimuli and the same average amount of time than the experimental participants but without any instruction to maintain their gaze or any feedback on their performance. Pre and post training measures will be obtained to assess cognitive and emotional changes after the training. DISCUSSION:The findings from this research will provide a proof-of-principle of the efficacy of eye-tracking paradigms to modify attentional biases and, consequently, to improve depressed mood. If the findings are positive, this new training approach may result in the improvement of cognitive bias modification procedures in depression. TRIAL REGISTRATION:This trial was retrospectively registered on July 28, 2016 with the ClinicalTrials.gov NCT02847793 registration number and the title 'Attentional Bias Modification Through Eye-tracker Methodology (ABMET)'.

Project description:BackgroundDexmedetomidine is increasingly used off-label in infants and children with cardiac disease during cardiopulmonary bypass (CPB) and in the postoperative period. Despite its frequent use, optimal dosing of dexmedetomidine in the setting of CPB has not been identified but is expected to differ from dosing in those not supported with CPB. This study had the following aims: (1) characterize the effect of CPB on dexmedetomidine clearance (CL) and volume of distribution (V) in infants and young children; (2) characterize tolerance and sedation in patients receiving dexmedetomidine; and (3) identify preliminary dosing recommendations for infants and children undergoing CPB. We hypothesized that CL would decrease, and V would increase during CPB compared to pre- or post-CPB states.MethodsOpen-label, single-center, opportunistic pharmacokinetics (PK) and safety study of dexmedetomidine in patients ≤36 months of age administered dexmedetomidine per standard of care via continuous infusion. We analyzed dexmedetomidine PK data using standard nonlinear mixed effects modeling with NONMEM software. We compared model-estimated PK parameters to those from historical patients receiving dexmedetomidine before anesthesia for urologic, lower abdominal, or plastic surgery; after low-risk cardiac or craniofacial surgery; or during bronchoscopy or nuclear magnetic resonance imaging. We investigated the influence of CPB-related factors on PK estimates and used the final model to simulate dosing recommendations, targeting a plasma concentration previously associated with safety and efficacy (0.6 ng/mL). We used the Wilcoxon rank sum test to evaluate differences in dexmedetomidine exposure between infants with hypotension or bradycardia and those who did not develop these adverse events.ResultsWe collected 213 dexmedetomidine plasma samples from 18 patients. Patients had a median (range) age of 3.3 months (0.1-34.0 months) and underwent CPB for 161 minutes (63-394 minutes). We estimated a CL of 13.4 L/h/70 kg (95% confidence interval, 2.6-24.2 L/h/70 kg) during CPB, compared to 42.1 L/h/70 kg (95% confidence interval, 38.7-45.8 L/h/70 kg) in the historical patients. No specific CPB-related factor had a statistically significant effect on PK. A loading dose of 0.7 µg/kg over 10 minutes before CPB, followed by maintenance infusions through CPB of 0.2 or 0.25 µg/kg/h in infants with postmenstrual ages of 42 or 92 weeks, respectively, maintained targeted concentrations. We identified no association between dexmedetomidine exposure and selected adverse events (P = .13).ConclusionsCPB is associated with lower CL during CPB in infants and young children compared to those not undergoing CPB. Further study should more closely investigate CPB-related factors that may influence CL.

Dataset Information

The image-scratch paradigm: a new paradigm for evaluating infants' motivated gaze control.

Publications

The image-scratch paradigm: a new paradigm for evaluating infants' motivated gaze control.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets